We defined patients with squamous cell carcinoma (SCC) with elevated carcinoembryonic antigen (CEA) ≥ 10 ng/mL, adenocarcinoma, or adenosquamous carcinoma as the high-risk group. This evidence concerns the gene CEACAM5 and squamous cell carcinoma.